4.1. Ethics
SECONDARY, POLAND
This secondary analysis stems from a prospective phase IV randomized placebo-controlled clinical trial (RCT) conducted at University Hospital no. 2 of the Pomeranian Medical University in Szczecin, Poland, spanning from December 2020 to August 2021. The study garnered approval from the Ethics Committee Board at the Pomeranian Medical University in Szczecin, Poland (ICE consent 0012/100/2020, issued on 29 June 2020), and it was duly registered on 